Holdings of iShares Health Innovation Active ETF
BlackRock ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 10.1M $ including 9.6M $ in equities, 95.6 %
- Positions
- 45 in 8 countries
- Top ten
- 42.6 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 3,459 | 795.1K $ | 7.88 % |
| 2 | Gilead Sciences Inc | 4,165 | 544.9K $ | 5.40 % |
| 3 | Edwards Lifesciences Corp | 5,726 | 478.1K $ | 4.74 % |
| 4 | Amgen Inc | 1,342 | 464.7K $ | 4.60 % |
| 5 | Merck & Co Inc | 3,620 | 395.2K $ | 3.92 % |
| 6 | Biogen Inc | 1,935 | 366.3K $ | 3.63 % |
| 7 | Wuxi Biologics Cayman Inc | 76,000 | 324.7K $ | 3.22 % |
| 8 | Waters Corp | 1,035 | 320.1K $ | 3.17 % |
| 9 | Mettler-Toledo International Inc | 245 | 312.8K $ | 3.10 % |
| 10 | Intuitive Surgical Inc | 651 | 297.9K $ | 2.95 % |
| 11 | Charles River Laboratories International Inc | 1,783 | 297.7K $ | 2.95 % |
| 12 | Vertex Pharmaceuticals Inc | 690 | 294.9K $ | 2.92 % |
| 13 | Argenx SE | 368 | 287.7K $ | 2.85 % |
| 14 | Moderna Inc | 5,804 | 266.6K $ | 2.64 % |
| 15 | Pfizer Inc | 9,393 | 250.8K $ | 2.48 % |
| 16 | Danaher Corp | 1,398 | 250.2K $ | 2.48 % |
| 17 | Bruker Corp | 6,389 | 234.5K $ | 2.32 % |
| 18 | Novartis AG | 1,579 | 233.4K $ | 2.31 % |
| 19 | Bio-Techne Corp | 3,805 | 210.5K $ | 2.09 % |
| 20 | Dexcom Inc | 3,493 | 208K $ | 2.06 % |
| 21 | GSK PLC | 3,926 | 205.4K $ | 2.03 % |
| 22 | Protagonist Therapeutics Inc | 2,031 | 201K $ | 1.99 % |
| 23 | Thermo Fisher Scientific Inc | 408 | 195.4K $ | 1.94 % |
| 24 | Roche Holding AG | 446 | 181.7K $ | 1.80 % |
| 25 | Insmed Inc | 1,326 | 180.8K $ | 1.79 % |
| 26 | AstraZeneca PLC | 875 | 163.9K $ | 1.62 % |
| 27 | UCB SA | 586 | 159.6K $ | 1.58 % |
| 28 | Cogent Biosciences Inc | 4,393 | 157.2K $ | 1.56 % |
| 29 | Incyte Corp | 1,645 | 156.7K $ | 1.55 % |
| 30 | IDEXX Laboratories Inc | 256 | 143.6K $ | 1.42 % |
| 31 | Boston Scientific Corp | 2,435 | 140.3K $ | 1.39 % |
| 32 | Bristol-Myers Squibb Co | 2,169 | 131.4K $ | 1.30 % |
| 33 | BioMarin Pharmaceutical Inc | 2,280 | 122.9K $ | 1.22 % |
| 34 | Teva Pharmaceutical Industries Ltd | 3,386 | 118.7K $ | 1.18 % |
| 35 | Revolution Medicines Inc | 723 | 104.2K $ | 1.03 % |
| 36 | Alcon AG | 1,360 | 101.8K $ | 1.01 % |
| 37 | Summit Therapeutics Inc | 3,507 | 75.3K $ | 0.75 % |
| 38 | Medline Inc | 1,459 | 64.9K $ | 0.64 % |
| 39 | Dianthus Therapeutics Inc | 651 | 57.2K $ | 0.57 % |
| 40 | BioNTech SE | 507 | 52.4K $ | 0.52 % |
| 41 | Apogee Therapeutics Inc | 576 | 47.7K $ | 0.47 % |
| 42 | Sagimet Biosciences Inc | 1,688 | 13.6K $ | 0.13 % |
| 43 | Erasca Inc | 1,251 | 13.3K $ | 0.13 % |
| 44 | Eikon Therapeutics Inc | 1,253 | 12K $ | 0.12 % |
| 45 | Ultragenyx Pharmaceutical Inc | 460 | 11.4K $ | 0.11 % |
Sector breakdown
- Health care 77.0 %
- Unattributed 23.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 90.7 %
- CHF 4.3 %
- HKD 3.4 %
- EUR 1.7 %
The quoted currency of each line, as declared.
Country breakdown
- United States 81.0 %
- Switzerland 5.4 %
- United Kingdom 3.8 %
- Hong Kong SAR China 3.4 %
- Netherlands 3.0 %
- Belgium 1.7 %
- Israel 1.2 %
- Germany 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 35 | 7.8M $ | 81.04 % |
| 2 | Switzerland | 3 | 516.9K $ | 5.36 % |
| 3 | United Kingdom | 2 | 369.3K $ | 3.83 % |
| 4 | Hong Kong SAR China | 1 | 324.7K $ | 3.37 % |
| 5 | Netherlands | 1 | 287.7K $ | 2.98 % |
| 6 | Belgium | 1 | 159.6K $ | 1.65 % |
| 7 | Israel | 1 | 118.7K $ | 1.23 % |
| 8 | Germany | 1 | 52.4K $ | 0.54 % |
Cite this page
Titelia. "Holdings of iShares Health Innovation Active ETF". https://titelia.com/en/funds/S000069260